Affordable Insulin Act of 2019
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in house (Feb 28, 2019)
Affordable Insulin Act of 2019
This bill addresses the importation of insulin from Canada and other foreign countries.
The bill requires the Food and Drug Administration (FDA) to promulgate regulations within 180 days permitting wholesalers, pharmacies, and individuals to import certain insulin from Canada. The FDA may also permit the importation of insulin from certain other countries under specified circumstances.
The bill also establishes a process for certifying licensed foreign pharmacies and foreign wholesale distributors.
What just happenedMar 1, 2019
Referred to the Subcommittee on Health.
Who’s behind it
- Introduced in HouseFeb 28, 2019
- Mar 1, 2019Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Feb 28, 2019IntroReferralH11100
Referred to the House Committee on Energy and Commerce.
Energy and Commerce Committee - Feb 28, 2019IntroReferralIntro-H
Introduced in House
- Feb 28, 2019IntroReferral1000
Introduced in House